Industry Seeks More Involvement In MDUFMA Guidance Development
This article was originally published in The Gray Sheet
Executive Summary
Device industry stakeholders are expressing a desire to collaborate more closely with FDA in developing and modifying guidance related to the Medical Device User Fee & Modernization Act
You may also be interested in...
FDA Should Allow Multiple Extensions For PMA Major Deficiencies – AdvaMed
MDUFMA performance goal review metrics outlined in agency guidance should be binding, and therefore established "through notice and comment rulemaking," AdvaMed contends
FDA Should Allow Multiple Extensions For PMA Major Deficiencies – AdvaMed
MDUFMA performance goal review metrics outlined in agency guidance should be binding, and therefore established "through notice and comment rulemaking," AdvaMed contends
Greater Modular Program Familiarity Needed To Set Performance Goals – FDA
FDA will defer issuing modular PMA performance goals until gaining more familiarity with the recently- codified process, agency officials informed attendees Dec. 3 at the MDUFMA one-year meeting in Gaithersburg, Md